29C1 Stock Overview Provides pharmacy services to seniors homes and other congregate care settings in Canada. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
CareRx Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for CareRx Historical stock prices Current Share Price CA$1.37 52 Week High CA$1.60 52 Week Low CA$0.91 Beta 0.88 1 Month Change 25.69% 3 Month Change 25.69% 1 Year Change 47.31% 3 Year Change -63.95% 5 Year Change -22.16% Change since IPO -82.16%
Recent News & Updates
Third quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.025 loss in 3Q 2023) Nov 10
CareRx Corporation to Report Q3, 2024 Results on Nov 08, 2024 Oct 31
CareRx Corporation Appoints Suzanne Brand as Chief Financial Officer, Effective October 1, 2024 Sep 05
Second quarter 2024 earnings released: CA$0.023 loss per share (vs CA$0.033 profit in 2Q 2023) Aug 09
CareRx Corporation to Report Q2, 2024 Results on Aug 08, 2024 Aug 02
CareRx Corporation Announces Board Changes May 30 See more updates
Third quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.025 loss in 3Q 2023) Nov 10
CareRx Corporation to Report Q3, 2024 Results on Nov 08, 2024 Oct 31
CareRx Corporation Appoints Suzanne Brand as Chief Financial Officer, Effective October 1, 2024 Sep 05
Second quarter 2024 earnings released: CA$0.023 loss per share (vs CA$0.033 profit in 2Q 2023) Aug 09
CareRx Corporation to Report Q2, 2024 Results on Aug 08, 2024 Aug 02
CareRx Corporation Announces Board Changes May 30 CareRx Corporation Announces CFO Transition May 15
First quarter 2024 earnings released: CA$0.009 loss per share (vs CA$0.039 loss in 1Q 2023) May 12
CareRx Corporation, Annual General Meeting, May 28, 2024 Mar 15
CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023 Mar 08
Full year 2023 earnings released: CA$94.25 loss per share (vs CA$0.72 loss in FY 2022) Mar 08
CareRx Corporation to Report Q4, 2023 Results on Mar 07, 2024 Mar 01
New minor risk - Share price stability Nov 29
New major risk - Revenue and earnings growth Nov 10
Third quarter 2023 earnings released: CA$0.025 loss per share (vs CA$0.038 loss in 3Q 2022) Nov 10
CareRx Corporation to Report Q3, 2023 Results on Nov 08, 2023 Nov 02
Second quarter 2023 earnings released: EPS: CA$0.033 (vs CA$0.53 loss in 2Q 2022) Aug 11
CareRx Corporation to Report Q2, 2023 Results on Aug 10, 2023 Aug 04
Less than half of directors are independent Jun 08
Carerx Corporation Announces Director Changes Jun 07
First quarter 2023 earnings released: CA$0.039 loss per share (vs CA$0.059 loss in 1Q 2022) May 10
Forecast breakeven date pushed back to 2025 Mar 12
Full year 2022 earnings released: CA$0.72 loss per share (vs CA$0.65 loss in FY 2021) Mar 10 CareRx Corporation has completed a Follow-on Equity Offering in the amount of CAD 8.0001 million. Jan 19
CareRx Corporation announced that it expects to receive CAD 8.0001 million in funding Jan 12
CareRx Announces Retirement of Dr. Jack Shevel as Director Effective December 31, 2022 Dec 08
Less than half of directors are independent Nov 16
Third quarter 2022 earnings released: CA$0.038 loss per share (vs CA$0.11 loss in 3Q 2021) Nov 10
CareRx Corporation to Report Q3, 2022 Results on Nov 09, 2022 Nov 01
Second quarter 2022 earnings released: CA$0.53 loss per share (vs CA$0.28 loss in 2Q 2021) Aug 16
Carerx Corporation Reports Goodwill and Intangible Assets Impairment Changes for the Three Months Ended June 30, 2022 Aug 16
CareRx Corporation to Report Q2, 2022 Results on Aug 15, 2022 Aug 09
President recently sold €171k worth of stock Jun 08
CareRx Corporation (TSX:CRRX) completed the acquisition of Hogan Pharmacy Partners Ltd. May 31
Forecast breakeven date pushed back to 2024 May 13
CareRx Corporation to Report Q1, 2022 Results on May 11, 2022 May 04
Less than half of directors are independent May 03
CareRx Corporation Announces Executive Changes Apr 03
CareRx Corporation, Annual General Meeting, Jun 07, 2022 Apr 02
CareRx Corporation (TSX:CRRX) entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd for $4.4 million. Apr 01
CareRx Corporation (TSX:CRRX) entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd for $4.4 million. Mar 31
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Mar 19
Carerx Corporation Expands the Scope and Product Offering of Its Medical Supplies Business Under A New Brand, Revicare Jan 22
Third quarter 2021 earnings released: CA$0.11 loss per share (vs CA$0.28 loss in 3Q 2020) Nov 11
Forecast to breakeven in 2022 Sep 23
CareRx Corporation (TSX:CRRX) completed the acquisition of Long-Term Care Pharmacy Division of Medical Pharmacies Group Limited for CAD 72.9 million. Aug 24
Second quarter 2021 earnings released: CA$0.28 loss per share (vs CA$0.75 loss in 2Q 2020) Aug 11
CareRx Corporation (TSX:CRRX) completed the acquisition of pharmacy fulfillment centre and portion of long-term care pharmacy services business of Rexall Pharma Plus Ltd. Jun 22
Director Lyle Oberg has left the company Jun 08
Director Peter Brown has left the company Jun 08
Forecast to breakeven in 2022 May 14
First quarter 2021 earnings released: CA$0.21 loss per share (vs CA$0.37 profit in 1Q 2020) May 14
CareRx Corporation (TSX:CRRX) acquired Fulfillment Centre in Thunder Bay, Ontario from Medical Pharmacies Group Limited. May 13
CareRx Corporation (TSX:CRRX) entered into a definitive agreement to acquire pharmacy fulfillment centre and portion of long-term care pharmacy services business of Rexall Pharma Plus Ltd. for CAD 3.5 million. Apr 27
CareRx Corporation announced that it expects to receive CAD 55.00056 million in funding from Yorkville Asset Management Inc. Apr 20
Full year 2020 earnings released: CA$0.90 loss per share (vs CA$4.16 loss in FY 2019) Mar 12
Revenue misses expectations Mar 12
CareRx Corporation to Report Q4, 2020 Results on Mar 10, 2021 Mar 04
CareRx Corporation and Think Research Corporation Announces Their Canada-Wide Partnership to Deliver Virtual Healthcare to Seniors Mar 03
New 90-day high: €3.16 Feb 13 CareRx Corporation announced that it has received CAD 6.244997 million in funding from Yorkville Asset Management Inc., and other investor CareRx Corporation announced that it expects to receive CAD 4.999998 million in funding from Yorkville Asset Management Inc., and another investor
New 90-day high: €2.90 Jan 28
New 90-day low: €2.22 Dec 15
CareRx Corporation Enters Multi-Year Pharmacy Services Agreement with an Ontario- Based Seniors Home Operator Dec 03
New 90-day low: €2.44 Nov 27
Revenue misses expectations Nov 07
Third quarter 2020 earnings released: CA$0.28 loss per share Nov 07
CareRx Corporation Announces Appointment of Puneet Khanna as Senior Vice President, Corporate Development Nov 03
CareRx Corporation to Report Q3, 2020 Results on Nov 05, 2020 Oct 29
Insider recently bought €56k worth of stock Oct 01
New 90-day low - €2.50 Sep 13
First half earnings released Aug 14
New 90-day high - €3.04 Aug 10
CareRx Corporation to Report Q2, 2020 Results on Aug 06, 2020 Aug 01
Centric Health Corporation (TSX:CHH) completed the acquisition of Remedy Holdings Inc. from Remedy Capital Corporation, 2642943 Ontario Inc., 2745995 Ontario Inc, Jeff May and others. Jul 30 Shareholder Returns 29C1 DE Consumer Retailing DE Market 7D 10.5% -6.2% -2.6% 1Y 47.3% -15.1% 6.9%
See full shareholder returns
Return vs Market: 29C1 exceeded the German Market which returned 6.9% over the past year.
Price Volatility Is 29C1's price volatile compared to industry and market? 29C1 volatility 29C1 Average Weekly Movement 6.8% Consumer Retailing Industry Average Movement 6.3% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.2% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 29C1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 29C1's weekly volatility (7%) has been stable over the past year.
About the Company CareRx Corporation, together with its subsidiaries, provides pharmacy services to seniors homes and other congregate care settings in Canada. The company offers medication management, technology, and program solutions. It serves long-term care homes, retirement homes, assisted living facilities, and group homes.
Show more CareRx Corporation Fundamentals Summary How do CareRx's earnings and revenue compare to its market cap? 29C1 fundamental statistics Market cap €81.57m Earnings (TTM ) -€3.97m Revenue (TTM ) €243.85m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 29C1 income statement (TTM ) Revenue CA$365.63m Cost of Revenue CA$259.23m Gross Profit CA$106.40m Other Expenses CA$112.35m Earnings -CA$5.96m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.099 Gross Margin 29.10% Net Profit Margin -1.63% Debt/Equity Ratio 65.8%
How did 29C1 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 05:56 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources CareRx Corporation is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Doug Cooper Beacon Securities Limited David Martin Bloom Burton & Co. Prasath Pandurangan Bloom Burton & Co.
Show 12 more analysts 
